Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) Sort descending | Title |
|---|---|---|---|
| RFA-MH-25-186 | August 14, 2024 | R21 | Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional) |
| PAR-22-101 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
| PAR-22-098 | December 10, 2024 | R21 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
| RFA-OD-22-007 | July 2, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
| PAR-22-236 | November 17, 2024 | R21 | Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed) |
| PAR-24-045 | November 20, 2024 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-23-299 | January 8, 2027 | R21 | Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) |
| RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
| PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
| NOT-OD-22-142 | March 17, 2025 | R21 | Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) |
| RFA-OD-21-007 | July 4, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
| NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
| PAR-24-046 | November 20, 2024 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
| NOT-ES-22-006 | May 8, 2025 | R21,F31,D43,K01,R03,K43,K99/R00,U01,U19,R01,F32,K23,F30,R21/R33 | Notice of Special Interest (NOSI): Climate Change and Health |
| NOT-OD-22-167 | October 5, 2025 | R21,R01,R34,UG3/UH3 | Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes |
| NOT-OD-22-179 | May 8, 2025 | R21,R01,R61/R33,UG3/UH3,R34,U01 | Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
| NOT-OD-22-178 | May 8, 2025 | R21,R01,UG3/UH3,R61/R33,R34,R03 | Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
| NOT-HD-23-003 | September 8, 2024 | R21,R03,R01 | Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals |
| NOT-OD-23-166 | May 8, 2026 | R21,R15,R01,R34,K25,K99/R00,K01,R03,P01,K08,K23 | Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations |
| PAR-23-318 | March 21, 2026 | R21/R33 | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
BACK TO TOP